CORT-AHF Study: Effect on Outcomes of Systemic Corticosteroid Therapy During Early Management Acute Heart Failure.
暂无分享,去创建一个
Héctor Martínez Alonso | A. Mebazaa | Ò. Miró | C. Mueller | E. Gayat | Koji Takagi | J. Jacob | D. Wussler | P. Llorens | F. Martín-Sánchez | V. Gil | J. M. Garrido | P. Herrero‐Puente | Cristina Gil | M. J. Pérez‐durá | M. L. López‐Grima | J. Tost | A. Alquézar | F. Richard | Francisco J Lucas Invernón | M. L. López-Grima
[1] F. Formiga,et al. INSUFICIENCIA CARDIACA AGUDA: BASICO CONOCER AL PACIENTE , 2018 .
[2] A. Mebazaa,et al. The BRONCH‐AHF study: effects on short‐term outcome of nebulized bronchodilators in emergency department patients diagnosed with acute heart failure , 2018, European journal of heart failure.
[3] S. Pocock,et al. Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort Study. , 2017, Annals of internal medicine.
[4] G. Filippatos,et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.
[5] Y. Sakata,et al. Incidence and predictors of in-hospital non-cardiac death in patients with acute heart failure , 2017, European heart journal. Acute cardiovascular care.
[6] P. Harjola,et al. [Can we do more for patients with acute heart failure before arrival at the hospital?] , 2017, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.
[7] Ò. Miró,et al. [Prehospital emergency care of patients with acute heart failure in Spain: the SEMICA study (Emergency Medical Response Systems for Patients with Acute Heart Failure)]. , 2017, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.
[8] John R. Hurst,et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline , 2017, European Respiratory Journal.
[9] G. Keijzers,et al. Heart failure in patients presenting with dyspnoea to the emergency department in the Asia Pacific region: an observational study , 2017, BMJ Open.
[10] Ò. Miró,et al. Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE-COPD study. , 2017, International journal of cardiology.
[11] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[12] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[13] Lisa A. Jacobson,et al. Approach to Adult Patients with Acute Dyspnea , 2015, Emergency Medicine Clinics of North America.
[14] R. Mentz,et al. COPD in heart failure: are there long-term implications following acute heart failure hospitalization? , 2015, Chest.
[15] Y. Kuo,et al. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. , 2014, Annals of the American Thoracic Society.
[16] G. Filippatos,et al. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity , 2014, Clinical Research in Cardiology.
[17] Chao Liu,et al. Cardiac Outcome Prevention Effectiveness of Glucocorticoids in Acute Decompensated Heart Failure: COPE-ADHF Study , 2014, Journal of cardiovascular pharmacology.
[18] Harlan M Krumholz,et al. Post-hospital syndrome--an acquired, transient condition of generalized risk. , 2013, The New England journal of medicine.
[19] Li Liang,et al. A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines Program , 2010, Circulation. Cardiovascular quality and outcomes.
[20] Mark V. Williams,et al. Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.
[21] Le Wang,et al. Prednisone adding to usual care treatment for refractory decompensated congestive heart failure. , 2008, International heart journal.
[22] B. Walker. Glucocorticoids and cardiovascular disease. , 2007, European journal of endocrinology.
[23] G. Tognoni,et al. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure , 2007, European journal of heart failure.
[24] P. Ponikowski,et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.
[25] J. Curtis,et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. , 2003, Chest.
[26] D. Levy,et al. Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.
[27] D. Rubin,et al. Large-sample significance levels from multiply imputed data using moment-based statistics and an F reference distribution , 1991 .
[28] P. Llorens. Risk assessment in emergency department patients with acute heart failure: We need to reach beyond our clinical judgment. , 2018, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.
[29] F. Formiga,et al. Acute heart failure: Understanding the patient is essential. , 2018, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.
[30] A. Singer,et al. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. , 2008, Annals of Emergency Medicine.